Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02396303Phase 1Unknown
Phase 1, randomised trial of carbetocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Bangabandhu Sheikh Mujib Medical University. Primary endpoint: Estimated blood loss after cesarean section at 24 hours. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02396303.